Join Stan Hanks, Aventurine General Partner, at the
IP Dealmakers conference December 8, 2020.
Moderated by Matt Moyers, this Investors Roundtable: Early Stage IP Investing Strategies will discuss:
• Hot Sectors for Investment
• Debt vs Equity Models: Pros and Cons
• Leveraging IP to Build Company Value
• Licensing, Litigation & Other Monetization Options
• ROI & Exit Strategies
We provide a human innovation ecosystem offering commercially focused support for inventors.
New science ventures offer significant opportunity and face unique challenges. Our innovative model is designed specifically for the development of Intellectual Property (IP) and IP rich early-stage companies. We provide in-depth advisory services, co-creation, IP strategy, education and direct access to a bench of highly experienced entrepreneurs in science and technology.
We bring foundational science and commercial viability together for social and market impact.
Scientific Research
Commercialization
